Oncology
Desmoid Tumours Are Not Benign to the People Living With Them
FDA has accepted Immunome’s NDA for varegacestat in adults with progressing desmoid tumours. The label may say non-metastatic. The burden can still be brutal.
Pancreatic Cancer Is Forcing Regulators to Move Faster
Ultra-processed food may leave a metabolic fingerprint in the blood.
Medicare Is Coming for the Oncology Margin
Early Lung Cancer Just Became a Biomarker Test of the System
Pancreatic Cancer’s ADC Moment Will Live or Die by the Biomarker
KRAS Has a New Contender. It Still Has to Earn Its Place.
China’s Biliary-Cancer Bet Has a Global Access Problem
A CE Mark Is Not Access
ALS Needs Proof, Not Just Another Biomarker
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.